Quality of lipid‐lowering therapy in patients with ischaemic heart disease: a register‐based study in 3477 patients
Authors:
- 10 February 2004
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 255 (3) , 367-372
Abstract
: Objective. To develop a method to evaluate routine management practices concerning lipid‐lowering treatment in patients with ischaemic heart disease (IHD) in a large geographic area.Design. A register‐based study linking information on IHD with cholesterol levels and prescriptions on lipid‐lowering medications by personal registration number. Plasma cholesterol levels were collected from the electronic laboratory information system (LIS), and information on IHD from the Danish National Hospital Register (LPR). The extent of treatment was evaluated by information on prescriptions on lipid‐lowering medications from the Danish National Health Service.Setting. Evaluates treatment in both hospitals and primary care.Subjects. Patients with IHD.Results. In total 3477 patients −1 set by European guidelines. In the 1521 patients treated with lipid‐lowering medications 55% reached the goal.Conclusion. By use of registers it was possible to develop a method to evaluate and monitor current treatment practice for dyslipidaemia in a large geographic area. The method makes it possible to evaluate the impact of guidelines, changes in treatment procedures and to provide feedback to physicians. The study revealed that lipid‐lowering treatment is still not sufficiently implemented in clinical practice even in patients with known IHD, and the used doses of statins are lower than those used in randomized clinical trials.Keywords
This publication has 15 references indexed in Scilit:
- Early Statin Treatment Following Acute Myocardial Infarction and 1-Year SurvivalJAMA, 2001
- The Lipid Treatment Assessment Project (L-TAP)Archives of internal medicine (1960), 2000
- The Effect of Recurrent Events on Register-Based Estimates of Level and Trends in Incidence of Acute Myocardial InfarctionJournal of Clinical Epidemiology, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol LevelsJAMA, 1998
- EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal resultsEuropean Heart Journal, 1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- A Framework for Evaluation of Secondary Data Sources for Epidemiological ResearchInternational Journal of Epidemiology, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Individualized drug utilization statisticsEuropean Journal of Clinical Pharmacology, 1994